Amundi
HRMY icon

Amundi’s Harmony Biosciences HRMY Stock Holding History

Amundi’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
16,131
+3,823
+31% +$121K ﹤0.01% 1588
2026
Q1 		$345K Buy
12,308
+5,931
+93% +$194K ﹤0.01% 1694
2025
Q4 		$239K Buy
+6,377
New +$210K ﹤0.01% 1713
2025
Q3 		– Sell
-6,373
Closed -$205K – 1631
2025
Q2 		$205K Sell
6,373
-33,295
-84% -$1.07M ﹤0.01% 1603
2025
Q1 		$1.23M Buy
39,668
+21,266
+116% +$762K ﹤0.01% 1277
2024
Q4 		$635K Buy
18,402
+13,041
+243% +$448K ﹤0.01% 1512
2024
Q3 		$186K Buy
5,361
+437
+9% +$15.3K ﹤0.01% 1670
2024
Q2 		$152K Buy
+4,924
New +$148K ﹤0.01% 1631

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's HRMY Position: Q2 2026 in Review

Amundi increased its Harmony Biosciences (HRMY) stake by 31% in Q2 2026, buying an estimated $121K and bringing the position to 16,131 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Amundi first reported a position in HRMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.23M in Q1 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Amundi held 16,131 shares of Harmony Biosciences worth $587K as of Q2 2026.
  • Amundi bought 3,823 Harmony Biosciences shares in Q2 2026, an estimated $121K.
  • Harmony Biosciences made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1588 holding.
  • Amundi first reported a position in Harmony Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Amundi's Harmony Biosciences position peaked at $1.23M in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.